These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 10385756)

  • 21. Getting ACE inhibitors into the right hands.
    Bilodeau A
    Manag Care; 1997 Jan; 6(1):31-2. PubMed ID: 10164530
    [No Abstract]   [Full Text] [Related]  

  • 22. ACCF and AHA Release Guidelines on the Management of Heart Failure.
    Armstrong C
    Am Fam Physician; 2014 Aug; 90(3):186-9. PubMed ID: 25077725
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cost-effectiveness of beta-blocker treatment in heart failure.
    Gilbert EM
    Rev Cardiovasc Med; 2002; 3 Suppl 3():S42-7. PubMed ID: 12447161
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differences between general practitioners and cardiologists in diagnosis and management of heart failure: a survey in every-day practice.
    Rutten FH; Grobbee DE; Hoes AW
    Eur J Heart Fail; 2003 Jun; 5(3):337-44. PubMed ID: 12798832
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multinational economic evaluation of valsartan in patients with chronic heart failure: results from the Valsartan Heart Failure Trial (Val-HeFT).
    Reed SD; Friedman JY; Velazquez EJ; Gnanasakthy A; Califf RM; Schulman KA
    Am Heart J; 2004 Jul; 148(1):122-8. PubMed ID: 15215801
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Margaret McCartney: Only data can say if new is better.
    McCartney M
    BMJ; 2017 May; 357():j2191. PubMed ID: 28483792
    [No Abstract]   [Full Text] [Related]  

  • 27. [Combination therapy of beta blockers for heart failure].
    Watanabe M; Hirata Y
    Nihon Rinsho; 2007 May; 65 Suppl 5():129-33. PubMed ID: 17571376
    [No Abstract]   [Full Text] [Related]  

  • 28. The pharmacological treatment of heart failure: are we looking at the sunset of the neurohormonal hypothesis.
    Porcu M
    Ital Heart J; 2002 Jul; 3(7):437-8. PubMed ID: 12189976
    [No Abstract]   [Full Text] [Related]  

  • 29. [Combination therapy with ARB for heart failure].
    Sakata Y
    Nihon Rinsho; 2007 May; 65 Suppl 5():123-7. PubMed ID: 17569310
    [No Abstract]   [Full Text] [Related]  

  • 30. [Drug therapy of heart failure. Don't wait until the legs swell].
    MMW Fortschr Med; 2002 Jul; 144(29-30):4-5. PubMed ID: 12219611
    [No Abstract]   [Full Text] [Related]  

  • 31. Incremental cost-effectiveness of guideline-directed medical therapies for heart failure.
    Banka G; Heidenreich PA; Fonarow GC
    J Am Coll Cardiol; 2013 Apr; 61(13):1440-6. PubMed ID: 23433562
    [TBL] [Abstract][Full Text] [Related]  

  • 32. New studies influencing treatment of heart failure: 2006 update.
    Dunlap ME
    Pharmacotherapy; 2007 Apr; 27(4 Pt 2):3S-11S. PubMed ID: 17381369
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Drug therapy and heart failure prevention.
    Linseman JV; Bristow MR
    Circulation; 2003 Mar; 107(9):1234-6. PubMed ID: 12628939
    [No Abstract]   [Full Text] [Related]  

  • 34. Health care and medication costs and use among older adults with heart failure.
    Stroupe KT; Teal EY; Weiner M; Gradus-Pizlo I; Brater DC; Murray MD
    Am J Med; 2004 Apr; 116(7):443-50. PubMed ID: 15047033
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Antiarrhythmic drug therapy in patients with heart failure].
    Nakamura K; Nishii N; Ohe T
    Nihon Rinsho; 2007 May; 65 Suppl 5():369-74. PubMed ID: 17571408
    [No Abstract]   [Full Text] [Related]  

  • 36. The scale of heart failure: diagnosis and management issues for primary care.
    Hobbs FD
    Heart; 1999 Dec; 82 Suppl 4(Suppl 4):IV8-IV10. PubMed ID: 10574904
    [No Abstract]   [Full Text] [Related]  

  • 37. American College of Cardiology/American Heart Association 2009 clinical guidelines for the diagnosis and management of heart failure in adults: update and clinical implications.
    Trupp RJ; Abraham WT
    Pol Arch Med Wewn; 2009; 119(7-8):436-8. PubMed ID: 19776682
    [No Abstract]   [Full Text] [Related]  

  • 38. Should patients receive secondary prevention medications for free after a myocardial infarction? An economic analysis.
    Choudhry NK; Avorn J; Antman EM; Schneeweiss S; Shrank WH
    Health Aff (Millwood); 2007; 26(1):186-94. PubMed ID: 17211028
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [History of cardiology in the last 100 years: Heart and vasoactive substances].
    Kinoshita M
    Nihon Naika Gakkai Zasshi; 2002 Mar; 91(3):828-31. PubMed ID: 11985086
    [No Abstract]   [Full Text] [Related]  

  • 40. Matters of the heart. Life-saving drugs for cardiac disease are still underused.
    Paul KJ
    Contemp Longterm Care; 1999 Jun; 22(6):53. PubMed ID: 10538230
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.